Biotechnology & Pharmaceuticals
Strategic IP solutions for companies that seek to reimagine therapies.
Biotechnology & Pharmaceuticals
Our seasoned Life Sciences team offers IP guidance to large and small companies as well as academic institutions in the Biotech and Pharma industries. We understand the unique pain points associated with forging a path and maintaining a competitive position in these patient-focused, high-growth industries.
Clients choose D&M because they can trust our individualized approach tailored to meet both research and business needs in a shared effort to bring life-saving therapies to patients.
We serve our clients in portfolio management, strategic advice and opinions, due diligence investigations, licensing activities, competitive intelligence analyses, counseling on regulatory matters, investor demands, and litigation under Hatch-Waxman, and the BPCIA.
In one of our recent matters, we designed and successfully executed a comprehensive patent prosecution strategy for a client launching a novel small-molecule inhibitor of hepatitis C virus (HCV).
Our expertise:
- Bioengineering
- Biosimilars and Biologics
- Biotechnology
- Biotherapeutics
- Cell therapy
- Diagnostics
- Drug delivery systems
- Fermentation and cell cultures
- Gene editing
- Gene therapy
- Immunology
- Nanotechnologies
- Nutraceuticals
- Pharmaceuticals
- Protein formulations
- Small molecule formulation
- Vaccine development
Find an IP professional and see what makes Dority & Manning different.
D&M’s full-service team is equipped to protect IP and maximize its value for clients. We combine your expertise with ours to build successful IP strategies and to create a strong unit built on trust.